Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions.
Jeffrey A CohenRobert A BermelCynthia I GrossmanCarrie M HershMegan HylandEllen M MowryRobert T NaismithMaria L NaylorJacqueline NicholasRajani RajbhandarCarol M SinghMar TintoreAnna ZabalzaTjalf ZiemssenJames R WilliamsXavier MontalbanPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Anti-CD20 therapies and S1PRMs reduce IgG response to SARS-CoV-2 vaccination; IgG response is preserved with other DMTs.